Table 2.
| No. of anti-Aβ seropositive mice |
Antibody titers (µg/ml) mean±S.E.M. |
Ig isotypes of Aβ42 antibodies |
|
|---|---|---|---|
| Week 7 | |||
| AdPEDI-(Aβ1-6)11 only | 5/10 | 1.8±1.2 | IgG1 >> IgG2aa |
| AdPEDI-(Aβ1-6)11 + simvastatin | 9/10 | 1.9±0.7 | IgG1 >> IgG2aa |
| Week 10 | |||
| AdPEDI-(Aβ1-6)11 only | 5/10 | 1.9±1.0 | IgG1 >> IgG2aa |
| AdPEDI-(Aβ1-6)11 + simvastatin | 7/10 | 2.3±0.9 | IgG1 >> IgG2aa |
| Week 13 | |||
| AdPEDI-(Aβ1-6)11 only | 6/10 | 2.5±0.8 | IgG1 >> IgG2aa |
| AdPEDI-(Aβ1-6)11 + simvastatin | 6/10 | 8.8±2.4b | IgG1 >> IgG2aa |
Characterization of anti-Aβ antibodies induced by AdPEDI-(Aβ1-6)11 vaccination with or without simvastatin.
Levels of anti-Aβ IgG2a were less than the minimum detectable level by the isotype-specific ELISA.
P = 0.03.